Sleep Apnea Pill Data Presented at ATS 2021: ‘These Data Reinforce…
The administration of reboxetine plus oxybutynin before bedtime greatly decreased OSA severity and increased next-day vigilance after 1 week.
The administration of reboxetine plus oxybutynin before bedtime greatly decreased OSA severity and increased next-day vigilance after 1 week.
Sleep Review’s CPAP adherence solutions guide compares options on parameters including supporting evidence, contact frequency, and more.
Sign up for emails, newsletters and print magazines from the leading Sleep Medicine Magazine and Journal
React Health was one of eight companies selected for the 2024 Zenith Award, which recognizes excellence in the respiratory care profession.
SomnoSeal, developed by Kimberly Hutchison, MD, FAASM, is a nasal breathing trainer designed to help sleep apnea patients reduce dry mouth and mouth leaks during…
Earn sleep continuing education credits our Aug/Sept 2024 digital edition, where the cover story is Q4 sleep study demand.
The Slow Wave DS8 (marketed as BROSA for bruxism) is the only prescription oral appliance in the United States with dual FDA clearance for treating…
A good night’s sleep involves cycling through stages with brief awakenings, with quality and consistent rest being key to feeling refreshed.
Surprisingly, the study found that cardiovascular diseases were not among the top comorbidities in people with narcolepsy.
A survey commissioned by the AASM reveals that nearly half of Americans are losing sleep due to anxiety surrounding the 2024 election.
The National Sleep Foundation released a report analyzing Americans’ sleep during the 2024 presidential election.